跳至主要内容
临床试验/NCT06055582
NCT06055582已完成不适用

A Randomized Controlled Study to Compare Effects of Mango Ingestion on Glycemia (Glycemic Response, Continuous Glucose Monitoring and Fructosamine) Insulin Resistance and Body Composition in Patients With T2DM and Non-diabetic Subjects.

Diabetes Foundation, India2 个研究点 分布在 1 个国家目标入组 130 人开始时间: 2022年2月11日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
130
试验地点
2
主要终点
Outcome for all the phases will be as follows

研究概览

简要总结

T2DM patient will be recruited from endocrine OPD

  1. Clinical History and Examination:

  2. General Physical Examination:

  • Height (cm)
  • weight (kg)
  • BMI (kg/m2)
  • Blood Pressure (mmHg)
  1. Anthropometry: Circumferences and skinfold thickness will be recorded for the patients in the following manner.

Circumferences:

  • Waist circumference (cm)
  • Hip circumference (cm)
  • Mid-arm circumference (cm)
  • Mid-thigh circumference (cm)
  1. Skin fold thickness: Skin fold thickness will be measured by using (LANGE skin fold calipers) (to nearest of 1 mm) at the following sites
  • Biceps (mm)
  • Triceps (mm)
  • Thigh (mm)
  • Calf (mm)
  • Sub scapular (mm)
  • Supra-iliac (mm)
  • Anterior axillary fold. (mm)
  1. Biochemical Test: The biochemical analysis will be done using ELISA kit or commercially available kits
  • Blood glucose (mg/dL)
  • HbA1c (%)
  • Serum insulin (μIU/mL)
  • Total Cholestrol (mg/dl)
  • Triglyceride (mg/dl)
  • Fructosamine (umol/L)
  • Adiponectin (µg/ml) -- HOMA-IR
  1. Body Composition Analysis (TANITA)

详细描述

  1. Phase I: Exploratory Acute Phase- Stratified randomized study
  • Study population: 2 groups; patients with T2DM and non-diabetic subjects n=45 (20 T2DM subject, 25 non-diabetic subjects).
  • Study groups: 3 groups; OGTT (n=5), mango (n=30), bread (n=10) Subjects in mango group will be further randomized into three different groups. Each group will be tested on a different variety of mango.

Procedure for Phase I:

After measuring baseline glucose level on empty stomach, three groups will be given their respective standardized food item and blood samples will be drawn every half an hour upto 2 hours of ingestion at (minutes): 0, 30, 60, 90 and 120. Fingertip capillary blood will be used for the estimation of blood glucose using a glucometer of contour brand. 2. Phase II: Exploratory Sub-Acute Phase- Two randomized cross over study

  • Study population: 2 groups; patients with T2DM and non-diabetic subjects, n=50 (25 in each study population group)
  • Study groups: 2 groups; mango (n=30), bread (n=20) Subjects in mango group will be further randomized into three different groups. Each group will be tested on a different variety of mango.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
None

盲法说明

Patients were recruited from Fortis C-DOC OPD.

入排标准

年龄范围
25 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • For patients with diabetes: Stable glycemic control on metformin or sulfonylurea for past 3 months and without any major complications and HbA1C less than 8%

排除标准

  • Acute infections and advanced end-organ damage
  • History of hepatitis or pancreatitis, abnormal liver and renal functions
  • Recent (<3 months) changes in weight
  • Any known allergy to mangoes and bread
  • Subjects with hypothyroidism
  • On any drug causing weight gain or weight loss.

结局指标

主要结局

Outcome for all the phases will be as follows

时间窗: Baseline, after six months of intervention

Fasting glucose (mg/dL)

Postprandial blood glucose (mg/dL)

时间窗: Baseline, after six months of intervention

Glycemic indices as per Continuous glucose monitoring system (CGMS) & HbA1c (%)

时间窗: Baseline, after six months of intervention

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr Anoop Misra

Director

Diabetes Foundation, India

研究点 (2)

Loading locations...

相似试验